Yahoo Web Search

Search results

  1. 5 days ago · Get the latest information on ImmunityBio (IBRX), a clinical-stage immunotherapy company, including its stock price, news, financials, statistics, forecast and profile. See how the company's products and pipeline are performing in the market and the industry.

    • Forecast

      Stock Price Forecast. The 1 analyst with a 12-month price...

    • Chart

      Interactive stock price chart for ImmunityBio, Inc. (IBRX)...

  2. People also ask

  3. 4 days ago · IBRX's current price target is $6.00. Learn why top analysts are making this stock forecast for ImmunityBio at MarketBeat.

    • (858) 633-0300
    • 3530 JOHN HOPKINS COURT, SAN DIEGO CA, 92121
    • investors@nantkwest.com
  4. 4 days ago · Should You Buy or Sell ImmunityBio Stock? Get The Latest IBRX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

    • (858) 633-0300
    • 3530 JOHN HOPKINS COURT, SAN DIEGO CA, 92121
    • investors@nantkwest.com
  5. 22 hours ago · Based on insights from the past three months, one analyst has set a consistent 12-month price target for IBRX at $6.00. This target reflects a slight decrease of 4.31% from its recent trading price of $6.27. Such a uniform forecast suggests a cautious but stable perspective on the company’s stock performance in the near term.

  6. 5 days ago · See the latest analyst ratings, price targets and revenue forecasts for ImmunityBio, a biotechnology company developing immunotherapies. The stock is expected to decline by 3.23% to 6.00 USD in the next 12 months.

  7. 4 days ago · What are your ImmunityBio, Inc. (IBRX) stock predictions? 2 Wall Street analysts have issued ratings. Currently, 1 analysts rated IBRX as Bullish, 0 rated it Bearish, and 1 rated it Neutral.

  8. 5 days ago · View ImmunityBio, Inc IBRX investment & stock information. Get the latest ImmunityBio, Inc IBRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

  1. People also search for